Arkolith/Insider Trading/KRON/Form 4

Knobelman Deborah

President & Interim CEOKronos Bio, Inc. (KRON) · full profile →Form 4 · filed Jun 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Tender(U)139K$0.57$79K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Disposed to issuer(D)246K—$00

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-017823) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML